Company
United StatesPublic company, NASDAQ: NKTRNektar Therapeutics (NASDAQ: NKTR), Huntsville, AL – FDA Inspections
Inspection records and compliance data for Nektar Therapeutics in Huntsville, Alabama. 1 FDA inspection on record, last inspected June 03, 2013. Publicly traded as NASDAQ: NKTR.
Company Profile
This profile covers Nektar Therapeutics based in Huntsville, Alabama, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 3, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 3, 2013 | NAI | Human Drugs · Drug Quality Assurance | 838048 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Magnesium Products, Inc.
Glacial Grain Spirits LLC
National Center for Natural Products Research, University of Mississippi
Pharmasyn, Inc.
API, Inc.
Holland Company, Inc.
Ohio Aluminum Chemicals, LLC
Nitto Denko Avecia, Inc
ELEMENT MATERIALS TECHNOLOGY SANTA CLARA INC.
ARENE LIFE SCIENCES (UNIT 3) PRIVATE LIMITED
Company Information
Name
Nektar Therapeutics
Stock ticker
NKTR
Exchange
NASDAQ
Share price
$37.25
Market cap
$1.3B
Price as of
November 13, 2026
FEI Number
3004979669
Address
1112 Church St Nw, Huntsville, Alabama 35801, United States
Country
United States
ID: 267237c5-8995-4d96-84d6-1b9350437de1